Literature DB >> 26076224

Nonmedicinal interventions in nonalcoholic fatty liver disease.

Manuela G Neuman, Radu M Nanau, Lawrence B Cohen.   

Abstract

Unhealthy diet and lack of physical exercise are responsible for fat accumulation in the liver, which may lead to liver disease. Histologically, the severity of the disease has two stages: nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). NAFLD is defined by the presence of steatosis with no evidence of cellular injury such as hepatocyte ballooning. NASH is a distinct entity from NAFLD, and is characterized by the presence of inflammation with hepatocytes damage, with or without fibrosis. While several therapeutic strategies have been proposed to improve this condition, the present review aims to discuss nonmedicinal interventions used to reduce liver involvement or to prevent the disease altogether. The authors investigated dietary patterns and vitamin deficiencies associated with NAFLD, and their role in enhancing disease severity. Additionally, they reviewed the role of exercise and the use of interventions, such as as intragastric balloon and bariatric surgery, for improving disease progression. The authors propose monitoring disease progression or repair by following changes in cytoadipokine levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26076224      PMCID: PMC4467484          DOI: 10.1155/2015/273595

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  123 in total

1.  Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.

Authors:  Henning Grønbæk; Aksel Lange; Niels H Birkebæk; Peter Holland-Fischer; Jan Solvig; Arne Hørlyck; Kurt Kristensen; Søren Rittig; Hendrik Vilstrup
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

Authors:  Alisan Kahraman; Jan-Peter Sowa; Martin Schlattjan; Svenja Sydor; Martin Pronadl; Alexander Wree; Anja Beilfuss; Alpaslan Kilicarslan; Akif Altinbaş; Lars Peter Bechmann; Wing-Kin Syn; Guido Gerken; Ali Canbay
Journal:  Clin Sci (Lond)       Date:  2013-10       Impact factor: 6.124

Review 3.  The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.

Authors:  Kyoko Nomura; Toshikazu Yamanouchi
Journal:  J Nutr Biochem       Date:  2011-11-29       Impact factor: 6.048

4.  Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.

Authors:  Priscila L Sanches; Aline de Piano; Raquel M S Campos; June Carnier; Marco T de Mello; Natália Elias; Francisco A H Fonseca; Deborah C L Masquio; Patrícia L da Silva; Flavia C Corgosinho; Lian Tock; Lila M Oyama; Sergio Tufik; Ana R Dâmaso
Journal:  J Clin Lipidol       Date:  2014-03-02       Impact factor: 4.766

5.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Luca Scala; Massimo Cigolini; Luciano Zenari; Giancarlo Falezza; Guido Arcaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-08-22       Impact factor: 4.222

6.  A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Authors:  Valentina Volynets; Jürgen Machann; Markus A Küper; Ina B Maier; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

Review 7.  Apoptosis in diseases of the liver.

Authors:  M G Neuman
Journal:  Crit Rev Clin Lab Sci       Date:  2001-04       Impact factor: 6.250

Review 8.  Biomarkers in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Lawrence B Cohen; Radu M Nanau
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

9.  Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.

Authors:  Laura Folini; Annamaria Veronelli; Alberto Benetti; Carlo Pozzato; Marco Cappelletti; Enzo Masci; Giancarlo Micheletto; Antonio E Pontiroli
Journal:  Acta Diabetol       Date:  2013-10-02       Impact factor: 4.280

10.  No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.

Authors:  Richard D Johnston; Mary C Stephenson; Hannah Crossland; Sally M Cordon; Elisa Palcidi; Eleanor F Cox; Moira A Taylor; Guruprasad P Aithal; Ian A Macdonald
Journal:  Gastroenterology       Date:  2013-07-19       Impact factor: 22.682

View more
  3 in total

Review 1.  Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-08-30       Impact factor: 5.810

Review 2.  The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Shanshan Zhu; Yuhui Wang; Fei Luo; Jie Liu; Liangchang Xiu; Jiheng Qin; Tao Wang; Na Yu; Hongfu Wu; Tangbin Zou
Journal:  Biomed Res Int       Date:  2019-07-14       Impact factor: 3.411

Review 3.  Role of Overweight and Obesity in Gastrointestinal Disease.

Authors:  Sara Emerenziani; Michele Pier Luca Guarino; Laura Maria Trillo Asensio; Annamaria Altomare; Mentore Ribolsi; Paola Balestrieri; Michele Cicala
Journal:  Nutrients       Date:  2019-12-31       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.